Norton Rose Fulbright advises HealthEZ on all aspects of its sale to Abry Partners

Global law firm Norton Rose Fulbright's New York, Washington, DC, Houston and St. Louis offices represented the shareholders of The Araz Group, Inc. (d/b/a HealthEZ) on all aspects of its June 30, 2020, sale to Abry Partners.

Norton Rose Fulbright advised HealthEZ—a leading independent third-party administrator (TPA) of self-funded medical plans—on all corporate, healthcare, regulatory, benefits, antitrust, real estate and tax matters for this complex transaction.

Founded in 1982, Minneapolis-based HealthEZ creates and administers custom health benefits solutions for employers, brokers, providers and members with all of their healthcare considerations. With a particular focus on the small- and mid-sized business (SMB) market, HealthEZ specializes in employer health and FSA benefits, consumer-driven health plans, and multi-state employers.

Andrew B. Roth (New York) led Norton Rose Fulbright's deal team. He was assisted by Michael Flamenbaum, David Gallai, Roy Goldman, Philip Michaels, William Stelwagon, Jason Lederman, Stephen Nelson, Susan Ross, Christopher Cash, Natalia Muzlayev (New York); Amanda Wait, Andrew Eklund (Washington, DC); Maxwell Karasek, Sarah Jean Kilker (St. Louis); and Jay Chadha (Houston).

Ranked as a leading practice in Chambers and Partners' 2020 USA directory, Norton Rose Fulbright's US healthcare team advises its clients on all aspects of healthcare law, including transactions, private and tax-exempt financings, healthcare fraud and abuse issues, healthcare facility construction and employment and labor matters.